US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Curanex Pharmaceuticals

4.75

+0.12002.59%

Pre-market: 4.35-0.4000-8.42%04:00 EDT

Volume:68.85K

Turnover:346.29K

Market Cap:7.45M

PE:-0.63

High:5.00

Open:4.41

Low:4.41

Close:4.63

52wk High:183.59

52wk Low:3.58

Shares:1.57M

Float Shares:454.66K

Volume Ratio:1.32

T/O Rate:15.14%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-7.5653

EPS(LYR):-3.3141

ROE:-411.08%

ROA:-225.06%

PB:1.56

PE(LYR):-1.43

Loading ...

Overview Company News Filings

Curanex Expands Scientific Advisory Board With Two Distinguished Researchers

THOMSON REUTERS

Curanex appoints Daniel Pascheles and Nicholas Meanwell to scientific advisory board

Curanex Appoints Two Veteran Industry Leaders to Scientific Advisory Board

THOMSON REUTERS

Curanex Pharmaceuticals signs CEO Jun Liu to $393,600 salary deal

Nasdaq Tumbles Over 350 Points; US Initial Jobless Claims Increase

Benzinga Earnings

What's Behind Curanex Pharmaceuticals (CURX) 56% Surge After Hours

Benzinga_recent_news

BRIEF-Curanex Provides Operational Update On Key Regulatory Milestones

Curanex provides operational update on regulatory milestones

Curanex completes GMP pilot-scale batch of Phyto-N for ulcerative colitis IND preparation

Curanex Provides Operational Update on Key Regulatory Milestones

THOMSON REUTERS

Curanex Pharmaceuticals Inc - Continues to Target Ind Submission for Ulcerative Colitis in Q4 2026

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/CURX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CURX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CURX\",,,,,undefined,":{"symbol":"CURX","market":"US","secType":"STK","nameCN":"Curanex Pharmaceuticals","latestPrice":4.75,"timestamp":1787688000000,"preClose":4.63,"halted":0,"volume":68847,"hourTrading":{"tag":"盘前","latestPrice":4.35,"preClose":4.75,"latestTime":"04:00 EDT","volume":4,"amount":17.4,"timestamp":1787731211288,"change":-0.4,"changeRate":-0.084211,"amplitude":0},"delay":0,"changeRate":0.025917926565874754,"floatShares":454655,"shares":1568240,"eps":-7.565286,"marketStatus":"Pre-Mkt","change":0.12,"latestTime":"08-26 05:18:48 EDT","open":4.4081,"high":5,"low":4.4081,"amount":346285.8488595,"amplitude":0.12784,"askPrice":5,"askSize":20,"bidPrice":3.99,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-7.565286,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787751000000},"marketStatusCode":1,"adr":0,"listingDate":1756180800000,"exchange":"NASDAQ","adjPreClose":4.75,"preHourTrading":{"tag":"盘前","latestPrice":4.35,"preClose":4.75,"latestTime":"04:00 EDT","volume":4,"amount":17.4,"timestamp":1787731211288,"change":-0.4,"changeRate":-0.084211,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":4.48,"preClose":4.75,"latestTime":"19:51 EDT","volume":60736,"amount":305477.3528,"timestamp":1787701889477,"change":-0.27,"changeRate":-0.056842,"amplitude":0.378947},"volumeRatio":1.3155721838207386},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CURX\",,,,,undefined,":{"symbol":"CURX","floatShares":454655,"roa":"-225.06%","roe":"-411.08%","lyrEps":-3.31414,"volumeRatio":1.3155721838207386,"shares":1568240,"dividePrice":0,"high":5,"amplitude":0.12784,"preClose":4.63,"low":4.4081,"week52Low":3.576,"pbRate":"1.56","week52High":183.592,"institutionHeld":0,"latestPrice":4.75,"committee":0.666667,"eps":-7.565286,"divideRate":0,"volume":68847,"delay":0,"ttmEps":-7.565286,"open":4.4081,"prevYearClose":6.612,"prevWeekClose":4.71,"prevMonthClose":4.104,"prevQuarterClose":5.304,"fiveDayClose":4.44,"twentyDayClose":3.96,"sixtyDayClose":6.652},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CURX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-20","symbol":"CURX","defaultRemindTime":1787232600000,"type":"split","dateTimestamp":1787198400000,"forFactor":20,"toFactor":1,"ratio":20}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CURX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CURX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CURX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CURX","date":"2026-08-25","current":-0.627868,"percent":0.987903,"low":-596.14306,"twenty":-38.902704,"median":-7.677342,"eighty":-1.196943,"high":-0.576326,"avg":-38.477541,"sd":105.314656,"marketCap":7260951},"quantilePoints":[{"date":"2025-08-29","current":-343.821021,"twenty":-323.7357,"median":-309.527845,"eighty":-285.033231,"marketCap":144022500},{"date":"2025-09-05","current":-470.352457,"twenty":-397.745937,"median":-357.40162,"eighty":-309.364317,"marketCap":197025000},{"date":"2025-09-12","current":-522.424684,"twenty":-490.623986,"median":-396.156013,"eighty":-317.040593,"marketCap":227272500},{"date":"2025-09-19","current":-81.3514,"twenty":-518.980126,"median":-404.105632,"eighty":-309.03726,"marketCap":35390625},{"date":"2025-09-26","current":-44.190079,"twenty":-502.869283,"median":-357.40162,"eighty":-78.227506,"marketCap":19224187},{"date":"2025-10-03","current":-52.064896,"twenty":-490.623986,"median":-308.710204,"eighty":-52.935681,"marketCap":22650000},{"date":"2025-10-10","current":-48.094947,"twenty":-477.242127,"median":-89.974648,"eighty":-50.763274,"marketCap":20922937},{"date":"2025-10-17","current":-45.236453,"twenty":-457.103092,"median":-68.335176,"eighty":-47.069268,"marketCap":19679395},{"date":"2025-10-24","current":-42.064901,"twenty":-400.925784,"median":-54.241859,"eighty":-44.399354,"marketCap":18299662},{"date":"2025-10-31","current":-42.99649,"twenty":-384.761559,"median":-51.4271,"eighty":-44.033885,"marketCap":18704935},{"date":"2025-11-07","current":-39.915076,"twenty":-365.54998,"median":-50.763274,"eighty":-43.476372,"marketCap":17364415},{"date":"2025-11-14","current":-36.025849,"twenty":-337.125914,"median":-49.550198,"eighty":-42.216596,"marketCap":15672469},{"date":"2025-11-21","current":-9.181804,"twenty":-310.01843,"median":-47.092697,"eighty":-39.195744,"marketCap":11917311},{"date":"2025-11-28","current":-10.640411,"twenty":-308.710204,"median":-46.699426,"eighty":-38.202616,"marketCap":13810477},{"date":"2025-12-05","current":-9.723323,"twenty":-249.517771,"median":-45.236453,"eighty":-36.025849,"marketCap":12620163},{"date":"2025-12-12","current":-10.048671,"twenty":-98.597896,"median":-44.065693,"eighty":-10.640411,"marketCap":13042441},{"date":"2025-12-19","current":-8.629367,"twenty":-81.3514,"median":-43.511146,"eighty":-10.14693,"marketCap":11200288},{"date":"2025-12-26","current":-8.727626,"twenty":-78.227506,"median":-43.029064,"eighty":-9.899316,"marketCap":11327822},{"date":"2026-01-02","current":-7.218797,"twenty":-71.979719,"median":-42.823377,"eighty":-9.635108,"marketCap":9369472},{"date":"2026-01-09","current":-8.085664,"twenty":-66.382742,"median":-40.152859,"eighty":-9.213247,"marketCap":10494602},{"date":"2026-01-16","current":-8.066012,"twenty":-59.883741,"median":-39.074691,"eighty":-8.778721,"marketCap":10469095},{"date":"2026-01-23","current":-7.948101,"twenty":-54.695471,"median":-38.768503,"eighty":-8.563861,"marketCap":10316055},{"date":"2026-01-30","current":-7.314874,"twenty":-52.092225,"median":-38.100754,"eighty":-8.186981,"marketCap":9494172},{"date":"2026-02-06","current":-5.851898,"twenty":-51.809778,"median":-36.025849,"eighty":-8.048981,"marketCap":7595337},{"date":"2026-02-13","current":-6.052785,"twenty":-51.302144,"median":-21.964742,"eighty":-8.00007,"marketCap":7856073},{"date":"2026-02-20","current":-6.982974,"twenty":-51.044424,"median":-10.640411,"eighty":-7.876918,"marketCap":9063391},{"date":"2026-02-27","current":-10.04212,"twenty":-50.763274,"median":-10.175316,"eighty":-7.808791,"marketCap":13033939},{"date":"2026-03-06","current":-8.714526,"twenty":-50.670859,"median":-10.110902,"eighty":-7.819272,"marketCap":11310818},{"date":"2026-03-13","current":-8.402278,"twenty":-50.150997,"median":-10.04212,"eighty":-7.828006,"marketCap":10905544},{"date":"2026-03-20","current":-9.280064,"twenty":-49.259148,"median":-9.875079,"eighty":-7.876918,"marketCap":12044845},{"date":"2026-03-27","current":-11.160095,"twenty":-47.902307,"median":-10.007184,"eighty":-7.935873,"marketCap":14484989},{"date":"2026-04-02","current":-3.420935,"twenty":-47.131746,"median":-10.007184,"eighty":-7.862943,"marketCap":14453814},{"date":"2026-04-10","current":-3.156639,"twenty":-47.053649,"median":-9.875079,"eighty":-7.677342,"marketCap":13337134},{"date":"2026-04-17","current":-2.999546,"twenty":-46.858406,"median":-9.825949,"eighty":-7.314874,"marketCap":12673398},{"date":"2026-04-24","current":-2.974706,"twenty":-46.540445,"median":-9.634889,"eighty":-7.070316,"marketCap":12568448},{"date":"2026-05-01","current":-2.799486,"twenty":-45.452654,"median":-9.498418,"eighty":-6.683829,"marketCap":11828126},{"date":"2026-05-08","current":-2.118748,"twenty":-45.236453,"median":-9.257136,"eighty":-6.550633,"marketCap":8951934},{"date":"2026-05-15","current":-2.100622,"twenty":-44.190079,"median":-9.17307,"eighty":-6.181613,"marketCap":8875349},{"date":"2026-05-22","current":-1.285435,"twenty":-44.13655,"median":-8.952531,"eighty":-5.851898,"marketCap":9303658},{"date":"2026-05-29","current":-1.343828,"twenty":-44.02318,"median":-8.880475,"eighty":-3.394795,"marketCap":9726294},{"date":"2026-06-05","current":-1.301111,"twenty":-43.831987,"median":-8.727626,"eighty":-3.148449,"marketCap":9417117},{"date":"2026-06-12","current":-1.320706,"twenty":-43.567172,"median":-8.671947,"eighty":-3.065336,"marketCap":9558941},{"date":"2026-06-18","current":-1.312868,"twenty":-43.485065,"median":-8.518006,"eighty":-2.978331,"marketCap":9502212},{"date":"2026-06-26","current":-1.022861,"twenty":-43.20451,"median":-8.38481,"eighty":-2.886089,"marketCap":7403215},{"date":"2026-07-02","current":-1.074592,"twenty":-43.016034,"median":-8.299652,"eighty":-2.787402,"marketCap":7777631},{"date":"2026-07-10","current":-0.83083,"twenty":-42.927245,"median":-8.1872,"eighty":-2.394668,"marketCap":6013340},{"date":"2026-07-17","current":-0.855128,"twenty":-42.519987,"median":-8.066012,"eighty":-2.13862,"marketCap":6189201},{"date":"2026-07-24","current":-0.783802,"twenty":-41.395198,"median":-8.034351,"eighty":-1.343985,"marketCap":5672962},{"date":"2026-07-31","current":-0.748531,"twenty":-40.29553,"median":-8.010332,"eighty":-1.321098,"marketCap":5417679},{"date":"2026-08-07","current":-0.763815,"twenty":-39.868052,"median":-7.948101,"eighty":-1.301503,"marketCap":5528301},{"date":"2026-08-14","current":-0.85983,"twenty":-39.558905,"median":-7.841107,"eighty":-1.285827,"marketCap":6223239},{"date":"2026-08-21","current":-0.713972,"twenty":-39.017362,"median":-7.806171,"eighty":-1.254867,"marketCap":7474124},{"date":"2026-08-25","current":-0.693608,"twenty":-38.902704,"median":-7.677342,"eighty":-1.196943,"marketCap":7260951}],"updateTime":1787733110307},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CURX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2618137369","title":"Curanex Expands Scientific Advisory Board With Two Distinguished Researchers","url":"https://stock-news.laohu8.com/highlight/detail?id=2618137369","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618137369?lang=en_us&edition=fundamental","pubTime":"2026-03-12 21:30","pubTimestamp":1773322200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nTUA8YLPBB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CURX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618247944","title":"Curanex appoints Daniel Pascheles and Nicholas Meanwell to scientific advisory board","url":"https://stock-news.laohu8.com/highlight/detail?id=2618247944","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618247944?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:03","pubTimestamp":1773230586,"startTime":"0","endTime":"0","summary":"Curanex appointed Daniel Pascheles and Nicholas A. Meanwell to its Scientific Advisory Board. Pascheles previously served as CEO and Partner at Molekule Consulting, and was Vice President and Head of Global Competitive Intelligence at Merck. Meanwell previously spent four decades at Bristol Myers Squibb, where he led drug discovery programs across cardiovascular, neurosciences, and virology. Curanex said the two advisors will support commercial strategy, product portfolio development, and go-to-market decisions.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL3klZct:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","LU0321505439.SGD","LU2242646821.SGD","LU0225771236.USD","LU1037948897.HKD","LU2361044949.HKD","LU0477156953.USD","BK4516","IE00BBT3K403.USD","IE00BLSP4239.USD","LU0006306889.USD","SG9999014005.SGD","LU0868494708.USD","LU1066051498.USD","LU1571399168.USD","LU1323610961.USD","SG9999015358.SGD","LU0203345920.USD","LU1989772923.USD","LU1032466523.USD","LU1934455863.HKD","LU0203347892.USD","SG9999014021.USD","LU0965509101.SGD","LU0238689110.USD","LU1057294990.SGD","LU1868837300.USD","LU1670710588.SGD","BK4588","LU0098860793.USD","LU1670710661.SGD","IE00BJT1NW94.SGD","LU1934455277.USD","LU2089984988.USD","BK4112","LU0122379950.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","LU1162221912.USD","LU0106261372.USD","BK4007","IE00BFTCPJ56.SGD","LU1093756168.USD","LU0096364046.USD","LU0114720955.EUR","LU0266013472.USD","LU1291159041.SGD","LU1093756325.SGD","SGXZ57979304.SGD","LU1670711040.USD","LU0861579265.USD","SG9999014013.SGD","LU0320765489.SGD","LU0965509283.SGD","LU1201861249.SGD","LU0265550946.USD","LU2210150020.SGD","LU1868836591.USD","LU2106854487.HKD","LU2133065610.SGD","IE00BLSP4452.SGD","LU0289739699.SGD","BK4532","LU0265550359.USD","SG9999014567.USD","LU1670711123.USD","IE00B2B36J28.USD","LU1868836914.USD","LU1035773651.USD","IE000M9KFDE8.USD","LU0942090050.USD","LU2112291526.USD","LU0306806265.USD","LU0234572021.USD","BK4534","LU0070302665.USD","SG9999001440.SGD","LU2360032135.SGD","LU1066051811.HKD","LU1917777945.USD","LU0648001328.SGD","SG9999001176.USD","LU0306807586.USD","LU2125154778.USD","LU1116320901.HKD","LU1983299246.USD","LU2361044865.SGD","IE0009355771.USD","LU0980610538.SGD","LU0882574055.USD","SG9999013999.USD","LU0985481810.HKD","SG9999001176.SGD","LU2023250504.SGD","SG9999014575.USD","IE00BN8TJ469.HKD","LU0965509010.AUD","LU1261432733.SGD","SG9999015341.SGD","LU2095319765.USD","SG9999014559.SGD","LU2468319806.SGD","IE00BSNM7G36.USD","LU1116320737.USD","LU1699723380.USD","SG9999002232.USD","SG9999014542.SGD","LU1974910355.USD","LU2242652126.USD","LU1883839398.USD","LU0130517989.USD","LU0985320562.USD","LU2125154935.USD","LU2361045086.USD","LU0208291251.USD","LU0130102774.USD","LU1934455194.USD","LU0211331839.USD","LU0314104364.USD","CURX","LU0061475181.USD","LU1037948541.HKD","LU1718418525.SGD","LU1585245621.USD","LU0225284248.USD","LU2210149790.SGD","LU2324357040.USD","LU1941712264.USD","BK4533","LU1941712348.USD","SG9999002224.SGD","IE00B1BXHZ80.USD","LU1868837136.USD","LU1929549753.HKD","IE00BJJMRZ35.SGD","LU1989772840.SGD","BK4550","LU0058720904.USD","LU1066053197.SGD","SG9999014039.USD","IE0002141913.USD","LU1989771016.USD","LU0432979614.USD","IE00B64PRP62.GBP","LU1061106388.HKD","LU1074936037.SGD","LU0965508806.USD","LU0267386448.USD","LU1868836757.USD","LU2023250843.SGD","BK4581","LU0320765646.SGD","LU2461242641.AUD","LU1066051225.USD","IE00BKPKM429.USD","LU0321505868.SGD","LU0456855351.SGD","IE00BFXG1179.USD","IE00BGHQF748.EUR","LU1430594728.SGD","BK4559","LU0868494617.USD","LU1069347547.HKD","BK4585","LU0237698245.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618594410","title":"Curanex Appoints Two Veteran Industry Leaders to Scientific Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2618594410","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618594410?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:00","pubTimestamp":1773230405,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nTUA7WDGJX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CURX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617658925","title":"Curanex Pharmaceuticals signs CEO Jun Liu to $393,600 salary deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2617658925","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617658925?lang=en_us&edition=fundamental","pubTime":"2026-03-07 05:31","pubTimestamp":1772832702,"startTime":"0","endTime":"0","summary":"Curanex Pharmaceuticals Inc. entered into an executive employment agreement with CEO and President Jun Liu effective March 1, 2026. The deal runs four years and sets an annual base salary of $393,600, continued participation in employee benefit plans and expense reimbursement, plus company-paid monthly automobile lease costs of $3,998. If Liu resigns for good reason or is terminated without cause, he would receive three months of continued base salary and benefits and immediate vesting of unvested options or restricted shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Curanex Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nNDLbybfwM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CURX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614115026","title":"Nasdaq Tumbles Over 350 Points; US Initial Jobless Claims Increase","url":"https://stock-news.laohu8.com/highlight/detail?id=2614115026","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614115026?lang=en_us&edition=fundamental","pubTime":"2026-02-26 23:51","pubTimestamp":1772121097,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/26/02/50894356/nasdaq-tumbles-over-350-points-us-initial-jobless-claims-increase","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELPW","TSYW.SI","GPIQ","QLD","ARRY","QQQJ","QQQM","BK4585","QYLG","LU0823414551.USD","QYLD","QQQY","ALBT","BK4096","QQQE","LU2357125470.USD","LU0823414478.USD","BK4588","PSQ","BK4122","AEHL","LU2294711713.HKD","LU1093756168.USD","BK4077","BK4233","SQQQ","NQmain","LU2249611893.SGD","CURX","GS",".IXIC","TQQQ","MNQmain","LU2506951792.HKD","JEPQ","LU1093756325.SGD","NVIW.SI","BK4205","LU1983299162.USD","USAW.SI","USJW.SI","EOSE","BK4086","BK4007","QID"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2614197092","title":"What's Behind Curanex Pharmaceuticals (CURX) 56% Surge After Hours","url":"https://stock-news.laohu8.com/highlight/detail?id=2614197092","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614197092?lang=en_us&edition=fundamental","pubTime":"2026-02-26 15:11","pubTimestamp":1772089860,"startTime":"0","endTime":"0","summary":"Curanex Pharmaceuticals shares surged in after-hours trading after the company completed a GMP-compliant batch supporting its planned IND submission for ulcerative colitis.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/26/Medication-In-Transparent-Capsules-On-A-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/26/Medication-In-Transparent-Capsules-On-A-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/26/02/50877222/whats-behind-curanex-pharmaceuticals-curx-56-surge-after-hours","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/02/50877222/whats-behind-curanex-pharmaceuticals-curx-56-surge-after-hours","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["RSI","BK4150","CURX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614805730","title":"BRIEF-Curanex Provides Operational Update On Key Regulatory Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2614805730","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614805730?lang=en_us&edition=fundamental","pubTime":"2026-02-25 21:39","pubTimestamp":1772026749,"startTime":"0","endTime":"0","summary":"BRIEF-Curanex Provides Operational Update On Key Regulatory MilestonesCuranex Pharmaceuticals Inc CURX.O:CURANEX PROVIDES OPERATIONAL UPDATE ON KEY REGULATORY MILESTONESCURANEX PHARMACEUTICALS INC - C","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nTUA4PTBXQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CURX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614087193","title":"Curanex provides operational update on regulatory milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2614087193","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614087193?lang=en_us&edition=fundamental","pubTime":"2026-02-25 21:17","pubTimestamp":1772025436,"startTime":"0","endTime":"0","summary":"Curanex (CURX) Pharmaceuticals announced the completion of a Good Manufacturing Practice-compliant pilot-scale batch of its lead botanical drug can...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/curanex-provides-operational-update-on-regulatory-milestones-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/curanex-provides-operational-update-on-regulatory-milestones-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CURX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614082255","title":"Curanex completes GMP pilot-scale batch of Phyto-N for ulcerative colitis IND preparation","url":"https://stock-news.laohu8.com/highlight/detail?id=2614082255","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614082255?lang=en_us&edition=fundamental","pubTime":"2026-02-25 21:02","pubTimestamp":1772024544,"startTime":"0","endTime":"0","summary":"Curanex Pharmaceuticals Inc. reported it has completed a GMP-compliant pilot-scale batch of its lead botanical drug candidate, Phyto-N, intended to support GLP toxicology, pharmacokinetic and other IND-enabling nonclinical studies. The company said it continues to target submission of its first FDA Investigational New Drug application for ulcerative colitis in the fourth quarter of 2026. Curanex also outlined CMC progress to date, including development of quality control methods for botanical raw materials and extracted drug substance, laboratory-scale process optimization covering extraction, concentration and drying, and scale-up production of GMP-compliant pilot material. In exploratory nonclinical work using laboratory-scale material, the company said non-GLP acute toxicity studies in rats and dogs did not identify treatment-related adverse toxicological findings, and hepatic microsomal metabolism studies showed minimal interspecies variability.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDL4zkZ7q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","LU2210150020.SGD","BK4007","BK4588","LU2095319765.USD","IE00B64PRP62.GBP","CURX","SG9999014013.SGD","SG9999014039.USD","BK4585","SG9999014021.USD","SG9999014005.SGD","IE00BKPKM429.USD","IE00BGHQF748.EUR","BK4112","LU0314104364.USD","IE00B3QW5Z07.USD","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614108218","title":"Curanex Provides Operational Update on Key Regulatory Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2614108218","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614108218?lang=en_us&edition=fundamental","pubTime":"2026-02-25 21:00","pubTimestamp":1772024407,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nTUA4PTBXQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CURX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614082128","title":"Curanex Pharmaceuticals Inc - Continues to Target Ind Submission for Ulcerative Colitis in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2614082128","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614082128?lang=en_us&edition=fundamental","pubTime":"2026-02-25 21:00","pubTimestamp":1772024407,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nTUA4PTBXQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CURX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":31,"code":"91000000","status":"200"}]}}